Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary Omega6/Omega3 PUFA intake

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Santoro, Nicola ^a   Savoye, Mary ^a   Kim, Grace ^a   Marotto, Katie ^a   Shaw, Melissa M ^a   Pierpont, Bridget ^a   Caprio, Sonia ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADOLESCENT; ARTICLE; CHILD; ETHNICITY; FAT CONTENT; FAT INTAKE; FATTY LIVER; FEMALE; GENE; GENE INTERACTION; GENOTYPE; HOMOZYGOTE; HUMAN; LIPID STORAGE; MALE; OBESITY; PNPLA3 GENE; SCHOOL CHILD;

ADIPOSE TISSUE; ADOLESCENT; CHILD; DIETARY FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY LIVER; FEMALE; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84861421970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037827     Document Type: Article

References (29)

1. Cali AM, De Oliveira AM, Kim H, Chen S, Reyes-Mugica M, et al. (2009) Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 49: 1896-903.
2. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-5.
3. Santoro N, Kursawe R, D'Adamo E, Dykas DJ, Zhang CK, et al. (2010) A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 52: 1281-90.
4. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, et al. (2010) I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 52: 1274-80.
5. Romeo S, Sentinelli F, Dash S, Yeo GS, Savage DB, et al. (2010) Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond). 34: 190-4.
6. Miraglia del Giudice E, Grandone A, Cirillo G, Santoro N, Amato A, et al. (2011) The Association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS One 6: e27933.
7. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA, (2010) Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet. 42: 21-3.
8. Romeo S, Huang-Doran I, Baroni MG, Kotronen A, (2010) Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein. Curr Opin Lipidol. 21: 247-52.
9. Davis JN, Lê KA, Walker RW, Vikman S, Spruijt-Metz D, et al. (2010) Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr. 92: 1522-7.
10. Huang Y, Cohen JC, Hobbs HH, (2011) Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem. 28; 286: 37085-93.
11. Perttilä J, Huaman-Samanez C, Caron S, Tanhuanpää K, Staels B, et al. (2012) PNPLA3 is Regulated by Glucose in Human Hepatocytes and its I148M Mutant Slows Down Triglyceride Hydrolysis. Am J Physiol Endocrinol Metab. In press.
12. Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, et al. (2006) How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr. 25: 816-23.
13. Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, et al. (2007) Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition. 23: 46-52.
14. Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, et al. (2012) Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol. In Press.
15. Molendi-Coste O, Legry V, Leclercq IA, (2011) Why and How Meet n-3 PUFA Dietary Recommendations? Gastroenterol Res Pract In press.
16. Wall R, Ross RP, Fitzgerald GF, Stanton C, (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids Nutr Rev 68: 280-289.
17. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, et al. (2004) Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 106: 635-43.
18. Xu J, Cho H, O'Malley S, Park JH, Clarke SD, (2002) Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and-2 in three distinct stages and by different mechanisms. J Nutr. 132: 3333-9.
19. Zivkovic AM, German JB, Sanyal AJ, (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 86: 285-300.
20. Santoro N, Zhang CK, Zhao H, Pakstis AJ, Kim, et al. (2012) Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 5: 781-789.
21. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA, (1997) Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 15: 287-293.
22. Kim H, Taksali SE, Dufour S, Befroy D, Goodman TR, et al. (2008) Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med. 59: 521-527.
23. Pacifico L, Martino MD, Catalano C, Panebianco V, Bezzi M, et al. (2011) T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease. World J Gastroenterol. 17: 3012-9.
24. Huang Y, He S, Li JZ, Seo YK, Osborne TF, et al. (2010) A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci U S A. 107: 7892-7.
25. Chen W, Chang B, Li L, Chan L, (2010) Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology.52: 1134-42.
26. Basantani MK, Sitnick MT, Cai L, Brenner DS, Gardner NP, et al. (2011) Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res. 52: 318-29.
27. Simopoulos AP, (2008) The Importance of the Omega6/Omega3 Fatty Acids Ratio in Cardiovascular Disease and Other Chronic Diseases. Exp Biol Med 233: 674-688.
28. He S, McPhaul C, Li JZ, Garuti R, Kinch L, et al. (2010) A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem. 285: 6706-15.
29. Mozaffarian D, Wu JH, (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 58: 2047-67.